[Considerable comorbidity in overweight adults: results from the Utrecht Health Project]
E A Molenaar1, M E Numans, E J C van Ameijden
1Afd. Klinische Epidemiologie, Universitair Medisch Centrum Utrecht, Julius Centrum voor Gezondheidswetenschappen en Eerstelijns Geneeskunde, Utrecht. e.a.molenaar@umcutrecht.nl
Nederlands Tijdschrift Voor Geneeskunde
|December 5, 2008
Summary
Overweight and obesity are linked to numerous physical and mental health issues, impacting quality of life. Measuring body mass index (BMI) in primary care can help identify at-risk individuals for early intervention.
Area of Science:
- Public Health
- Epidemiology
- Primary Care Medicine
Context:
- A large, dynamic primary care population study (Utrecht Health Project) provided baseline data.
- The study included 4825 adult participants with a mean age of 39 years, 55% of whom were women.
- A response rate exceeding 50% ensured robust data representation.
Purpose:
- To investigate the association between overweight/obesity and physical/mental health conditions.
- To examine the relationship between body mass index (BMI) categories and health-related quality of life.
- To compare health outcomes between normal weight, overweight, and obese individuals within a primary care setting.
Summary:
- Overweight individuals showed increased risks for cardiovascular factors, back pain, arthrosis, migraine, dyspepsia, and respiratory issues compared to normal weight individuals.
- Obese individuals faced higher odds for these conditions, plus obstructive pulmonary disease, cardiovascular disease, and arthritis.
- Both overweight and obese groups experienced more somatization and reduced physical well-being; obesity was also linked to increased mental health conditions and reduced mental well-being.
Impact:
- Findings highlight the significant comorbidity burden associated with overweight and obesity.
- Routine BMI measurement at primary care entry can facilitate early identification of high-risk patients.
- This proactive approach may improve patient outcomes and reduce healthcare costs associated with chronic conditions.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...